Deck Kelly — SEC Form 4 filings
SEC reporting owner CIK 1819427. 9 Form 4 filings on record with FilingPulse; latest filed 2025-04-02.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-06 to 2025-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibrx, Inc. (INBX) | Chief Financial Officer | 7 | — | — | 17 |
| Inhibrx Biosciences, Inc. (INBX) | Chief Financial Officer | 2 | — | — | 2 |
Form 4 filings — Deck Kelly
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-02 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Inhibrx, Inc. (INBX) | Disposition to issuer (D): 9,167 (derivative) · Disposition to issuer (D): 14,583 (derivative) · Disposition to issuer (D): 21,250 (derivative) | EDGAR |
| 2024-05-30 | 4 | Inhibrx Biosciences, Inc. (INXB) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 17,624 (derivative) @ $34.24 · Option exercise (M): 2,087 (derivative) @ $34.24 | EDGAR |
| 2024-03-28 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 396 (derivative) @ $35.40 · Option exercise (M): 416 (derivative) @ $35.40 · Option exercise (M): 1,459 (derivative) @ $35.40 · Option exercise (M): 625 (derivative) @ $35.40 | EDGAR |
| 2024-03-22 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 16,777 (derivative) @ $35.02 · Option exercise (M): 3,113 (derivative) @ $35.09 · Option exercise (M): 110 (derivative) @ $35 | EDGAR |
| 2024-03-15 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 32,431 (derivative) @ $35.43 | EDGAR |
| 2024-03-12 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 42,523 (derivative) @ $35.75 | EDGAR |
| 2024-03-06 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 8,125 (derivative) @ $35.60 · Option exercise (M): 53,958 (derivative) @ $35.40 · Option exercise (M): 10,417 (derivative) @ $35.72 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1819427 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →